In eastern China, the mutation frequencies of GPR126 intron 6, TERT, and PLEKHS1 promoters in UUT-UC patients were significantly lower than those in patients with bladder cancer (63). This evidence concerns the gene ADGRG6 and urinary bladder carcinoma.